Back to search

Article

DHHC7 palmitoylates KRAS4A and promotes mutant KRAS-driven pancreatic cancers

2026-04-02

Abstract excerpt

KRAS mutations underlie many human cancers. While inhibitors such as Sotorasib and Adagrasib targeting KRAS mutants have shown promise, additional strategies are required to address the broader spectrum of KRAS-driven cancers, particularly those displaying drug resistance. Thus, there is a need to better understand KRAS signaling and develop new therapeutic strategies. Here we show that KRAS4A is palmitoylated on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6828aed2-9e01-5740-9f2e-a58c23c2470d
DOI
10.64898/2026.03.31.715686
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DHHC7 palmitoylates KRAS4A and promotes mutant KRAS-driven pancreatic cancersDOI 10.64898/2026.03.31.715686
Select a neighboring publication to make it the new centre.